Art
J-GLOBAL ID:201902230860348006   Reference number:19A1286706

Novel Approach for the Search for Chemical Scaffolds with Activity at Both Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptor: A Perspective on Scaffolds with Dual Activity for the Treatment of Neurodegenerative Disorders

アセチルコリンエステラーゼとα7ニコチン性アセチルコリン受容体の両方で活性を持つ化学足場を探索するための新規アプローチ:神経変性疾患の治療のための二重活性を持つ足場に関する展望【JST・京大機械翻訳】
Author (12):
Material:
Volume: 24  Issue:Page: 446  Publication year: 2019 
JST Material Number: U7014A  ISSN: 1420-3049  CODEN: MOLEFW  Document type: Article
Article type: 原著論文  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Neurodegenerative disorders, i...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1286706&from=J-GLOBAL&jstjournalNo=U7014A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (3):
JST classification
Category name(code) classified by JST.
Basic research of enzyme preparations and enzyme inhibitor preparations  ,  Enzyme in general  ,  Basic research of other drugs acting on central nervous system 
Reference (51):
  • Reiman, E.M.; Quiroz, Y.T.; Fleisher, A.S.; Chen, K.; Velez-Pardo, C.; Jimenez-Del-Rio, M.; Fagan, A.M.; Shah, A.R.; Alvarez, S.; Arbelaez, A.; et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer’s disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 2012, 11, 1048-1056.
  • Grossberg, G.T.; Edwards, K.R.; Zhao, Q. Rationale for combination therapy with galantamine and memantine in Alzheimer’s disease. J. Clin. Pharm. 2006, 46, 17s-26s.
  • Zhao, X.; Marszalec, W.; Toth, P.T.; Huang, J.; Yeh, J.Z.; Narahashi, T. In vitro galantamine-memantine co-application: Mechanism of beneficial action. Neuropharmacology 2006, 51, 1181-1191.
  • Lopes, J.P.; Tarozzo, G.; Reggiani, A.; Piomelli, D.; Cavalli, A. Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity. Brain Behav. 2013, 3, 67-74.
  • Atri, A.; Molinuevo, J.L.; Lemming, O.; Wirth, Y.; Pulte, I.; Wilkinson, D. Memantine in patients with Alzheimer’s disease receiving donepezil: New analyses of efficacy and safety for combination therapy. Alzheimer’s Res. 2013, 5, 6.
more...

Return to Previous Page